EDGAR Filing Documents for 0001615774-15-002842

Form 8-K - Current report:

SEC Accession No. 0001615774-15-002842

Filing Date

2015-10-06

Accepted

2015-10-06 08:45:32

Documents

Period of Report

2015-09-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	s101972_8k.htm	8-K	27443
2	EXHIBIT 10.1	s101972_ex10-1.htm	EX-10.1	183475
3	EXHIBIT 10.2	s101972_ex10-2.htm	EX-10.2	968553
4	EXHIBIT 10.3	s101972_ex10-3.htm	EX-10.3	401211
5	EXHIBIT 99.1	s101972_ex99-1.htm	EX-99.1	12594
	Complete submission text file	0001615774-15-002842.txt		1594777

Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158

Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300

NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)